Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

Jesper van Breeschoten, Michel W J M Wouters, Doranne L Hilarius, John B Haanen, Christian U Blank, Maureen J B Aarts, Franchette W P J van den Berkmortel, Jan-Willem B de Groot, Geke A P Hospers, Ellen Kapiteijn, Djura Piersma, Roos S van Rijn, Karijn P M Suijkerbuijk, Willeke A M Blokx, Bert-Jan J Ten Tije, Astrid A M van der Veldt, Art Vreugdenhil, Marye J Boers-Sonderen, Alfonsus J M van den Eertwegh

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Number of pages1
JournalBritish Journal of Cancer
DOIs
Publication statusE-pub ahead of print - 2021

Cite this